P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim results

Brian Bressler, Dirk Demuth, M Bassel et al.|Journal of Crohn s and Colitis|2018

Cited by 4